Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Tatva Chintan Pharma Chem Limited, is an unlisted public company incorporated on 12 June, 1996. It is classified as a public limited company and is located in Bharuch, Gujarat. It's authorized share capital is INR 40.00 cr and the total paid-up capital is INR 23.39 cr.
Tatva Chintan Pharma Chem Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2021. It's EBITDA has increased by 24.43% over the previous year. At the same time, it's book networth has increased by 41.49%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2021 numbers.
14.71%
24.43%
46.9%
41.49%
-3.97%
26.24%
1.22
1.75
3.59
1.17
0.2
-0.22
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(6)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
ICICI Bank Limited
No. of Loans: 3
Total Amount : 169.2 cr
CitiBank N.A.
No. of Loans: 3
Total Amount : 121.5 cr
State Bank of India
No. of Loans: 1
Total Amount : 45.0 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 35.0 cr
Axis Bank Limited
No. of Loans: 3
Total Amount : 3.3 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Chintan Nitinkumar Shah
Shareholder
|
00183618 | 28 years |
| Whole-time Director | Shekhar Rasiklal Somani
Shareholder
|
00183665 | 28 years |
| Whole-time Director | Ajaykumar Mansukhlal Patel
Shareholder
|
00183745 | 28 years |
| Director | Subhash Ambubhai Patel | 00535221 | 4 years |
| Director | Manher Chimanlal Desai | 09042598 | 4 years |
| Director | Avani Rajesh Umatt | 09046170 | 4 years |
| Kmp | Ashok Bothra | <HIDDEN> | 3 years |
| Kmp | Ishwar Ramanbhai Nayi | <HIDDEN> | 3 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| CATALYST ORGANICS PRIVATE LIMITED |
Strike Off
|
1.0 L | 3 | Gujarat |
| OSMOSIS AGRICULTURE RESEARCH TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| DREAMS STOCK BROKERS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Gujarat |
| HEMANI INDUSTRIES LIMITED |
Active
|
45.0 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Tatva Chintan Europe BV | Netherlands | - | - |
| Tatva Chintan USA Inc | United States | - | - |
| Tatva Chintan Europe BV | Netherlands | - | - |
The incorporation date of TATVA CHINTAN PHARMA CHEM LIMITED is 12 June, 1996
The authorized share capital of TATVA CHINTAN PHARMA CHEM LIMITED is INR ₹ 40.0 Cr.
The paid-up capital of TATVA CHINTAN PHARMA CHEM LIMITED is INR ₹ 23.4 Cr.
The registered address of TATVA CHINTAN PHARMA CHEM LIMITED is Plot No 502/17 GIDC Estate Ankleshwar GIDC NA Ankleshwar Bharuch Gujarat - 393002
The CIN number of TATVA CHINTAN PHARMA CHEM LIMITED is L24232GJ1996PLC029894.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
